JP2004508327A5 - - Google Patents

Download PDF

Info

Publication number
JP2004508327A5
JP2004508327A5 JP2002524492A JP2002524492A JP2004508327A5 JP 2004508327 A5 JP2004508327 A5 JP 2004508327A5 JP 2002524492 A JP2002524492 A JP 2002524492A JP 2002524492 A JP2002524492 A JP 2002524492A JP 2004508327 A5 JP2004508327 A5 JP 2004508327A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002524492A
Other languages
Japanese (ja)
Other versions
JP2004508327A (ja
Filing date
Publication date
Priority claimed from US09/655,760 external-priority patent/US6414016B1/en
Application filed filed Critical
Publication of JP2004508327A publication Critical patent/JP2004508327A/ja
Publication of JP2004508327A5 publication Critical patent/JP2004508327A5/ja
Pending legal-status Critical Current

Links

JP2002524492A 2000-09-05 2001-09-04 下剤組成物 Pending JP2004508327A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/655,760 US6414016B1 (en) 2000-09-05 2000-09-05 Anti-constipation composition
PCT/JP2001/007628 WO2002020007A1 (en) 2000-09-05 2001-09-04 Cathartic composition

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009050902A Division JP4684334B2 (ja) 2000-09-05 2009-03-04 下剤組成物

Publications (2)

Publication Number Publication Date
JP2004508327A JP2004508327A (ja) 2004-03-18
JP2004508327A5 true JP2004508327A5 (ref) 2005-12-22

Family

ID=24630250

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2002524492A Pending JP2004508327A (ja) 2000-09-05 2001-09-04 下剤組成物
JP2009050902A Expired - Fee Related JP4684334B2 (ja) 2000-09-05 2009-03-04 下剤組成物
JP2009213058A Pending JP2009286806A (ja) 2000-09-05 2009-09-15 下剤組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2009050902A Expired - Fee Related JP4684334B2 (ja) 2000-09-05 2009-03-04 下剤組成物
JP2009213058A Pending JP2009286806A (ja) 2000-09-05 2009-09-15 下剤組成物

Country Status (25)

Country Link
US (7) US6414016B1 (ref)
EP (2) EP1857105B1 (ref)
JP (3) JP2004508327A (ref)
KR (2) KR100901102B1 (ref)
CN (1) CN100335049C (ref)
AR (2) AR030609A1 (ref)
AT (1) ATE476975T1 (ref)
AU (2) AU8261501A (ref)
BR (1) BRPI0114042B8 (ref)
CA (1) CA2419741C (ref)
CZ (1) CZ304740B6 (ref)
DE (2) DE60142810D1 (ref)
DK (2) DK1315485T3 (ref)
ES (2) ES2347697T3 (ref)
HU (1) HU229319B1 (ref)
IL (2) IL154534A0 (ref)
MX (1) MXPA03001959A (ref)
NL (1) NL300757I1 (ref)
NO (1) NO332701B1 (ref)
NZ (1) NZ524401A (ref)
PT (2) PT1857105E (ref)
RU (1) RU2694361C3 (ref)
TW (1) TWI305147B (ref)
WO (1) WO2002020007A1 (ref)
ZA (1) ZA200301673B (ref)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0014869B8 (pt) * 1999-10-15 2021-05-25 Sucampo Ag prostaglandinas bicíclicas, composições estabilizadas das mesmas, bem como processo para sua estabilização
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI302100B (en) * 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
AR037524A1 (es) 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
US7732487B2 (en) * 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
DK1562604T3 (da) * 2002-10-23 2012-04-02 Sucampo Ag Prostaglandinforbindelser til behandling af fedme
KR101164838B1 (ko) * 2002-12-27 2012-07-11 수캄포 아게 복부 불쾌감 치료용 프로스타글랜딘의 유도체
EP1641462B1 (en) 2003-07-03 2010-11-24 Sucampo AG Enteric coated composition comprising prostaglandin analogs as chloride channel opener
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
TWI387454B (zh) * 2004-09-02 2013-03-01 蘇坎波公司 治療胃腸道疾病之方法及組成物
RU2392941C2 (ru) * 2004-09-02 2010-06-27 Сукампо Аг Производные простагландинов для лечения желудочно-кишечного нарушения
TWI384988B (zh) 2005-01-27 2013-02-11 Sucampo Ag 處理中樞神經系統失常用之組成物
DK1853271T3 (da) 2005-03-04 2011-01-24 Sucampo Ag Fremgangsmåde og præparat til behandling af perifere vaskulære sygdomme
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
BRPI0608818A2 (pt) * 2005-03-07 2010-01-26 Univ Chicago uso de antagonista opióides para atenuação de proliferação e migração de células endoteliais
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
US20060281818A1 (en) 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
AU2006234632B2 (en) * 2005-04-12 2011-10-27 Sucampo Ag Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders
AU2007208637B2 (en) * 2006-01-24 2012-04-26 R-Tech Ueno, Ltd. Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
CN103804338A (zh) * 2006-02-07 2014-05-21 株式会社·R-技术上野 用于制备前列腺素衍生物的方法
US20090030072A1 (en) * 2007-07-03 2009-01-29 Sucampo Ag Pharmaceutical combination of opioid and prostaglandin compound
US20090012165A1 (en) * 2007-07-03 2009-01-08 Sucampo Ag Pharmaceutical combination of nsaid and prostaglandin compound
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
CN101318948B (zh) * 2008-04-01 2011-04-27 上海天伟生物制药有限公司 鲁比前列酮晶体、其制备方法及用途
US8513441B2 (en) * 2008-08-29 2013-08-20 Alphora Research Inc. Prostaglandin synthesis and intermediates for use therein
CN102245176B (zh) * 2008-10-31 2015-05-27 脂质医药有限公司 用作药物的脂肪酸
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
KR101766619B1 (ko) 2008-12-31 2017-08-08 알데릭스, 인코포레이티드 체액 저류 또는 염 과부하와 연관된 장애 및 위장관 장애의 치료 시에 ｎｈｅ-매개된 역수송을 억제하는 화합물 및 방법
CA2750487A1 (en) 2009-01-22 2010-07-29 Apotex Pharmachem Inc. Methods of making lubiprostone and intermediates thereof
US9084815B2 (en) * 2009-09-16 2015-07-21 Sucampo Ag Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor
NZ598783A (en) * 2009-09-18 2013-07-26 Adolor Corp Use of opioid receptor antagonist for gastrointestinal tract disorders
CA2779736A1 (en) * 2009-11-03 2011-05-12 Bernard Charles Sherman Stable pharmaceutical formulations comprising lubiprostone
WO2011072383A1 (en) * 2009-12-18 2011-06-23 Apotex Pharmachem Inc. Processes for the purification of lubiprostone
EP2536705A4 (en) 2010-01-28 2013-08-07 Apotex Pharmachem Inc POLYMORPHIC FORMS OF LUBIPROSTON
HK1211469A1 (en) 2012-08-21 2016-05-27 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
AU2014250956B2 (en) 2013-04-12 2019-04-04 Ardelyx, Inc. NHE3-binding compounds and methods for inhibiting phosphate transport
EP3277274B1 (en) 2015-04-01 2024-06-12 Cedars-Sinai Medical Center Anti-methanogenic lovastatin analogs or derivatives and uses thereof
AR105029A1 (es) * 2015-06-19 2017-08-30 Sucampo Ag Composición farmacéutica que comprende derivado de ácido graso
JP6957610B2 (ja) 2016-10-06 2021-11-02 スキャンポ・アーゲーＳｕｃａｍｐｏ ＡＧ 医薬品用途のための多層ビーズ
KR102669987B1 (ko) 2017-01-09 2024-05-31 알데릭스, 인코포레이티드 위장관 장애를 치료하는 데 유용한 화합물
BR112019013963A2 (pt) 2017-01-09 2020-04-28 Ardelyx Inc inibidores de antiporte mediado por nhe
WO2018193572A1 (ja) * 2017-04-20 2018-10-25 株式会社島津製作所 分光光度計
US10422729B1 (en) 2019-03-08 2019-09-24 Biodesix, Inc. Blood sample separation devices and methods

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5720305B2 (ref) 1973-02-28 1982-04-27
US4034003A (en) 1974-04-11 1977-07-05 Ono Pharmaceutical Co., Ltd. 15-Cycloalkyl-prostaglandins
JPS5350141A (en) 1976-10-18 1978-05-08 Ono Pharmaceut Co Ltd Stabilization of prostaglandin and prostaglandin analogues
JPS5391110A (en) 1977-01-20 1978-08-10 Yamanouchi Pharmaceut Co Ltd Novel drug composition for rectal infusion
JPS6022708B2 (ja) 1977-07-14 1985-06-03 小野薬品工業株式会社 プロスタグランジン類似化合物
US4308595A (en) * 1979-12-19 1981-12-29 International Business Machines Corporation Array driver
US4670569A (en) 1981-04-02 1987-06-02 G. D. Searle & Co. 5-fluoro-PGI2 compounds
US4579958A (en) 1983-12-23 1986-04-01 G. D. Searle & Co. 5-fluoro-3-oxa-6,7-didehydro-PGI1 compounds
US4687864A (en) 1983-12-23 1987-08-18 G. D. Searle & Co. 5-fluoro-3-oxa-prostacyclin compounds
US5166174A (en) * 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
US5317032A (en) 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
JPH0681728B2 (ja) * 1987-10-02 1994-10-19 株式会社上野製薬応用研究所 下 剤
GB2210556B (en) 1987-10-02 1991-07-17 Ueno Seiyaku Oyo Kenkyujo Kk The use of 15-keto-16-halo-prostaglandins in cathartic compositions
JP2579193B2 (ja) 1988-07-19 1997-02-05 小野薬品工業株式会社 １６，１６−ジフルオロ−１５−オキソ−１５−デオキシｐｇｅ誘導体
CA2030345C (en) 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
CA2030346C (en) * 1989-11-22 2000-04-11 Ryuji Ueno Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
ATE174221T1 (de) * 1990-05-01 1998-12-15 R Tech Ueno Ltd Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
JP2515442B2 (ja) * 1990-05-01 1996-07-10 株式会社上野製薬応用研究所 膵臓疾患処置剤
JP2938579B2 (ja) 1990-12-15 1999-08-23 株式会社上野製薬応用研究所 消化管壁保護剤
CA2150287C (en) 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
AUPO665397A0 (en) * 1997-05-07 1997-05-29 Borody, Thomas Julius Novel therapy for constipation
ATE246506T1 (de) * 1998-03-11 2003-08-15 Grelan Pharmaceutical Co Darmlösliche sprudelnde zusammensetzungen
US6471085B1 (en) 1999-10-04 2002-10-29 Anthony J. Gallo Temperature cup
BRPI0014869B8 (pt) * 1999-10-15 2021-05-25 Sucampo Ag prostaglandinas bicíclicas, composições estabilizadas das mesmas, bem como processo para sua estabilização
DE50107923D1 (de) * 2000-07-14 2005-12-08 Henkel Kgaa Kompartiment-hohlkörper enthaltend wasch-, reinigungs- oder spülmittelportion
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition

Similar Documents

Publication Publication Date Title
BE2022C531I2 (ref)
BE2022C547I2 (ref)
BE2022C502I2 (ref)
BE2017C059I2 (ref)
BE2017C057I2 (ref)
BE2017C051I2 (ref)
BE2017C032I2 (ref)
BE2016C051I2 (ref)
BE2015C046I2 (ref)
BE2014C052I2 (ref)
BE2014C036I2 (ref)
FR11C0042I1 (ref)
BE2014C006I2 (ref)
BRPI0209186B1 (ref)
BE2017C050I2 (ref)
BRPI0204884A2 (ref)
CH1379220H1 (ref)
BE2014C008I2 (ref)
BE2016C021I2 (ref)
DE60225805D1 (ref)
BRPI0101486B8 (ref)
JP2002216458A5 (ref)
BRPI0210463A2 (ref)
HU0202061D0 (ref)
BRMU8103221U (ref)